Last reviewed · How we verify
Lumentin® 44 Powder for oral foam — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lumentin® 44 Powder for oral foam (Lumentin® 44 Powder for oral foam) — Lument AB.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lumentin® 44 Powder for oral foam TARGET | Lumentin® 44 Powder for oral foam | Lument AB | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lumentin® 44 Powder for oral foam CI watch — RSS
- Lumentin® 44 Powder for oral foam CI watch — Atom
- Lumentin® 44 Powder for oral foam CI watch — JSON
- Lumentin® 44 Powder for oral foam alone — RSS
Cite this brief
Drug Landscape (2026). Lumentin® 44 Powder for oral foam — Competitive Intelligence Brief. https://druglandscape.com/ci/lumentin-44-powder-for-oral-foam. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab